Effectiveness of Norepinephrine-Vasopressin Combination in Reducing Mortality in Septic Shock Patients: A Scoping Review
Abstract
Keywords
Full Text:
PDFReferences
Ammar, M. A., Limberg, E. C., Lam, S. W., Ammar, A. A., Sacha, G. L., Reddy, A. J., and Bauer, S. R. (2019). Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock. Journal of Critical Care, 53, 69–74. https://doi.org/10.1016/j.jcrc.2019.05.024
Bai, X., Yu, W., Ji, W., Lin, Z., Tan, S., Duan, K., and Li, N. (2014). Early versus delayed administration of norepinephrine in patients with septic shock. Critical Care 2014, 18(5), 1–8. 10.1186/S13054-014-0532-Y
Chen, C., Pang, L., Wang, Y., Wen, T., Yu, W., Yue, X., and Liao, W. (2019). Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials. Annals of Translational Medicine, 7(20), 535–535. 10.21037/atm.2019.09.134
Cheng, L., Yan, J., Han, S., Chen, Q., Chen, M., Jiang, H., and Lu, J. (2019). Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials. Critical care, 23(1), 168. https://doi.org/10.1186/s13054-019-2427-4
Dugar, S., Choudhary, C., and Duggal, A. (2020). Sepsis and septic shock: Guideline-based management. Cleveland Clinic Journal of Medicine, 87(1), 53–64. 10.3949/CCJM.87A.18143
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., and Reinhart, K. (2016). Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. American Journal of Respiratory and Critical Care Medicine, 193(3), 259–272. 10.1164/rccm.201504-0781OC
Mahmoud, K., and Ammar, A. (2012). Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock. Indian Journal of Critical Care Medicine, 16(2), 75–80. 10.4103/0972-5229.99110
McIntyre, W. F., Um, K. J., Alhazzani, W., Lengyel, A. P., Hajjar, L., Gordon, A. C.,and Belley-Côté, E. P. (2018). Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock a systematic review and meta-Analysis. JAMA - Journal of the American Medical Association, 319(18), 1889–1900. 10.1001/jama.2018.4528
Oba, Y., and Lone, N. A. (2014). Mortality benefit of vasopressor and inotropic agents in septic shock: A Bayesian network meta-analysis of randomized controlled trials. Journal of Critical Care, 29(5), 706–710. 10.1016/j.jcrc.2014.04.011
Ospina-Tascón, G. A., Hernandez, G., and Bakker, J. (2020). Should we start vasopressors very early in septic shock? Journal of Thoracic Disease, 12(7), 3893. 10.21037/JTD.2020.02.21
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer L., Tetzlaff, J.M., Aki, E.A., Brennan, S.E., Chou, R., Glanville, J., Grimshaw, J.M., Hróbjartsson, A., Lalu, M.M., Li, T., Loder, E.W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., Stewart, L.A., Thomas, J., Tricco, A.C., Welch, V.A., Whiting, P., and Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLOS Medicine, 18(3), e1003583. 10.1371/JOURNAL.PMED.1003583
Permpikul, C., Tongyoo, S., Viarasilpa, T., Trainarongsakul, T., Chakorn, T., and Udompanturak, S. (2019). Early use of norepinephrine in septic shock resuscitation (CENSER) a randomized trial. American Journal of Respiratory and Critical Care Medicine, 199(9), 1097–1105. 10.1164/rccm.201806-1034OC
Pollard, S., Edwin, S. B., and Alaniz, C. (2015). Vasopressor and Inotropic Management Of Patients With Septic Shock. Pharmacy and Therapeutics, 40(7), 438. Retrieved from /pmc/articles/PMC4495871/
Raza, H. A., Arshad, A., Ayaz, A., Raja, M. H. R., Gauhar, F., Khan, M., and Jamil, B. (2020). Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country. Critical Care Explorations, 2(11), e0274. 10.1097/CCE.0000000000000274
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., and Dellinger, R. P. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. In Intensive Care Medicine. 43. 10.1007/s00134-017-4683-6
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., and Naghavi, M. (2020). Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet, 395(10219), 200–211. 10.1016/S0140-6736(19)32989-7
Russel, J. A. (2019). Vasopressor therapy in critically ill patients with shock. Intensive Care Medicine, 45(11), 1503–1517. 10.1007/s00134-019-05801-z
Seymour, C. W., Liu, V. X., Iwashyna, T. J., Brunkhorst, F. M., Rea, T. D., Scherag, A., and Angus, D. C. (2016). Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA: Journal of the American Medical Association, 315(8), 762–774. 10.1001/JAMA.2016.0288
Shankar-Hari, M., Phillips, G. S., Levy, M. L., Seymour, C. W., Liu, V. X., Deutschman, C.S., Angus, D.C., Rubenfeld, G.D., and Singer, M. (2016). Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA: Journal of the American Medical Association, 315(8), 775–787. 10.1001/JAMA.2016.0289
Sinto, R., Suwarto, S., and Widodo, D. (2018). Comparison of Survival Prediction with Single versus Combination Use of Microcirculation End Point Resuscitation in Sepsis and Septic Shock. Acta Medica Indonesiana, 50(4), 275–282.
Vincent, J. L., and De Backer, D. (2013). Circulatory shock. The New England journal of medicine, 369(18), 1726–1734. https://doi.org/10.1056/NEJMra1208943
Zhou, F., Mao, Z., Zeng, X., Kang, H., Liu, H., Pan, L., and Hou, P. C. (2015). Vasopressors in septic shock: A systematic review and network meta-analysis. Therapeutics and Clinical Risk Management, 11, 1047–1059. 10.2147/TCRM.S80060
Refbacks
- There are currently no refbacks.